Coherus Oncology, Inc. - Common Stock (CHRS)

CUSIP: 19249H103

Q1 2019 13F Holders as of 31 Mar 2019

Holder snapshot 7 signals
Share change
+3,047,118
Put/Call ratio
39%
SEC-reported price per share
$13.64
Indexed holders
114
Value change
+$43,941,561
Number of buys
63
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
154,050,897

Security key

19249H103

Report period

Q1 2019

Indexed institutions

114

Top holders

10

Ownership snapshot

Top reported holders of CHRS - Coherus Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
0/15
Latest evidence
31 Dec 2018
13F Highest disclosed value: $69,354,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $69.35M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Disclosed position value Top 5
WELLINGTON MANAGEMENT GROUP LLP $69.35M
Temasek Holdings (Private) Ltd $59.33M
BlackRock Finance, Inc. $42.74M
FMR LLC $41.45M
JPMORGAN CHASE & CO $33.77M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$69,354,000
7,663,457 shares
— 31 Dec 2018
Temasek Holdings (Private) Ltd
13F
Company
13F
—
denominator unverified
$59,333,000
6,556,116 shares
— 31 Dec 2018
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$42,739,000
4,722,418 shares
— 31 Dec 2018
FMR LLC
13F
Company
13F
—
denominator unverified
$41,451,000
4,580,229 shares
— 31 Dec 2018
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$33,774,000
3,731,881 shares
— 31 Dec 2018
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
13F
—
denominator unverified
$27,648,000
3,055,055 shares
— 31 Dec 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
114
Shares
68,742,401
Indexed holders
114
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 indexed holders
107
Q1 2019 indexed holders
114
Indexed holder difference
7
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .